AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.

Also called NCT07684690

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07684690
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07684690. Randomized; single masking; primary purpose treatment. Start 2026-07 (anticipated); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
Acronym
AI-ADCS
Condition
Type 2 Diabetes Mellitus (T2DM)
Intervention (Device)
AI-assisted antidiabetic drug consultation system
Intervention (Other)
Manual antidiabetic prescribing (without AI)
Lead sponsor
National Taiwan University Hospital (class: other)

Record details

Record id
cardio:ct-nct07684690
Content hash
fc52a446f78ada0218b40f291d60c9273bd60fe243f3339f3ab19e4457b237e9